Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Electro-Alfa International announced the early closure of its Initial Public Offer (IPO) for the sale of up to 65.9 million newly issued shares.
BRD Groupe Société Générale reported strong commercial performance in 2025, with net loans outstanding growing 13% year-on-year to RON 56.1 billion(€11.01 billion).
Forvis Mazars Group has released its annual C-suite barometer showing that 92% of global executives expect growth in 2026, despite ongoing economic uncertainty.
Data from financial analysis platform RisCo.ro reveals clear differences between Romania's largest employers. State companies dominate the ranking by employee count, but private firms lead significantly in turnover, profit and efficiency per employee.
Romania's Ministry of Finance has published a legislative package aimed at establishing mechanisms to support strategic investments and accelerate the country's economic recovery.